Preclinical studies of a PARP targeted, Meitner-Auger emitting, theranostic radiopharmaceutical for metastatic ovarian cancer
针对转移性卵巢癌的 PARP 靶向、迈特纳-奥格发射、治疗诊断放射性药物的临床前研究
期刊:Nuclear Medicine and Biology
影响因子:3.6
doi:10.1016/j.nucmedbio.2023.108368
S L V Hoffman, J C Mixdorf, O Kwon, T R Johnson, M Makvandi, H Lee, E Aluicio-Sarduy, T E Barnhart, J J Jeffery, M S Patankar, J W Engle, B P Bednarz, P A Ellison
